Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial-Reference-Cited by-同舟云学术

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Published:2018-03 Issue:3 Volume:18 Page:296-307
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Guery Benoit,Menichetti Francesco,Anttila Veli-Jukka,Adomakoh Nicholas,Aguado Jose Maria,Bisnauthsing Karen,Georgopali Areti,Goldenberg Simon D,Karas Andreas,Kazeem Gbenga,Longshaw Chris,Palacios-Fabrega Jose Alejandro,Cornely Oliver A,Vehreschild Maria J G T

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference25 articles.

1. Consequences of Clostridium difficile infection: understanding the healthcare burden;Bouza;Clin Microbiol Infect,2012

2. Clostridium difficile infection in Europe: a hospital-based survey;Bauer;Lancet,2011

3. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection;Debast;Clin Microbiol Infect,2014

4. A review of mortality due to Clostridium difficile infection;Karas;J Infect,2010

5. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line;Aguado;J Hosp Infect,2015

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis;Medicine;2024-08-09

2. Management of Clostridioides difficile infection: an Italian Delphi consensus;Journal of Antimicrobial Chemotherapy;2024-07-13

3. Fighting against Clostridioides difficile infection: Current medications;International Journal of Antimicrobial Agents;2024-07

4. Editorial zur Aktualisierung der S2k-Leitlinie Gastrointestinale Infektionen v2.0;Zeitschrift für Gastroenterologie;2024-07

5. S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS);Zeitschrift für Gastroenterologie;2024-07